The present invention relates, in general, to micro RN As and. in particular, to viral microRNAs expressed by Herpes Simplex Vims 1 (HSV-1) or Herpes Simplex Virus 2 (HSV-2), to agents that inhibit such microRNAs and to methods of treatment based on the use of such agents.
CULLEN BRYAN R [US]; LIN UMBACH JENNIFER [US]; COEN DONALD M [US]; KRAMER MARTHA F [US]; JURAK IGOR [US]; KNIPE DAVID [US]
Type of Offer:
« More Biotech Patents